Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 526 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 301-325 of 526 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Nov 2020
Reporting date
24 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38327

10-Q Q3 2020

Filing date
09 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Oct 2020
Reporting date
03 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Oct 2020
Reporting date
29 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Sep 2020
Reporting date
17 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
18 Sep 2020
Reporting date
17 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2020
Reporting date
21 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
10 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38327

10-Q Q2 2020 CUE

Filing date
07 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
15 Jul 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
26 Jun 2020
Reporting date
24 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2020
Reporting date
24 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
22 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .